Cholecalciferol 100 000 UI — Competitive Intelligence Brief

Cholecalciferol 100 000 UI (Cholecalciferol 100 000 UI) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D supplement. Area: Endocrinology / Bone Health / Immunology.

marketed Vitamin D supplement Vitamin D receptor (VDR) Endocrinology / Bone Health / Immunology Small molecule

Target snapshot

Cholecalciferol 100 000 UI (Cholecalciferol 100 000 UI) — University Hospital, Tours. Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Cholecalciferol 100 000 UI TARGET	Cholecalciferol 100 000 UI	University Hospital, Tours	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Vitamin D3 tablets	Vitamin D3 tablets	Ain Shams University	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
oral cholecalciferol + life style counselling	oral cholecalciferol + life style counselling	Post Graduate Institute of Medical Education and Research, Chandigarh	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
ergocalciferol (vitamin D2)	ergocalciferol (vitamin D2)	Atlanta VA Medical Center	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Devit-3 Oral Drop	Devit-3 Oral Drop	Zekai Tahir Burak Women's Health Research and Education Hospital	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Cholecalciferol Pill	Cholecalciferol Pill	Hospital Infantil de Mexico Federico Gomez	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Cholecalciferol (vitamin D)	Cholecalciferol (vitamin D)	University of Tromso	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D supplement class)

1. Hospices Civils de Lyon · 2 drugs in this class
2. Assistance Publique - Hôpitaux de Paris · 1 drug in this class
3. Atlanta VA Medical Center · 1 drug in this class
4. Barts & The London NHS Trust · 1 drug in this class
5. Centre of Postgraduate Medical Education · 1 drug in this class
6. Hospital Infantil de Mexico Federico Gomez · 1 drug in this class
7. Post Graduate Institute of Medical Education and Research, Chandigarh · 1 drug in this class
8. University Hospital, Tours · 1 drug in this class
9. University of Alabama at Birmingham · 1 drug in this class
10. Amgen · 1 drug in this class